ID   VLN6H2
AC   CVCL_8010
DR   CLO; CLO_0009541
DR   ATCC; HB-8633
DR   Wikidata; Q54993207
RX   Patent=US4761377;
RX   PubMed=3621203;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8633.
CC   Monoclonal antibody isotype: IgG1, kappa.
CC   Monoclonal antibody target: Human 68 kDa antigen on cell surface of A-431.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D039 ! UC 729-6
CA   Hybridoma
DT   Created: 04-04-12; Last updated: 30-01-24; Version: 8
//
RX   Patent=US4761377;
RA   Glassy M.C., Surh C.D.;
RT   "Human-human hybrid cell lines that produce antibodies against
RT   antigenic determinants on cancer cells.";
RL   Patent number US4761377, 02-Aug-1988.
//
RX   PubMed=3621203;
RA   Glassy M.C.;
RT   "Immortalization of human lymphocytes from a tumor-involved lymph
RT   node.";
RL   Cancer Res. 47:5181-5188(1987).
//